Brief: Clearpoint Neuro Announces FDA Clearance For Software Version 2.1
19/09/2022 21:34
Sept 19 (Reuters) - Clearpoint Neuro Inc CLPT.O :
* CLEARPOINT NEURO ANNOUNCES FDA CLEARANCE FOR SOFTWARE
VERSION
2.1
* CLEARPOINT NEURO INC- ANNOUNCED THAT IT HAS OBTAINED
510(K)
CLEARANCE FOR VERSION 2.1 OF CLEARPOINT NEURO NAVIGATION
SOFTWARE
Source text for Eikon: ID:nGNX9lrLtb
Further company coverage: CLPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearpoint Neuro
See all newsClearpoint Neuro Inc reports results for the quarter ended June 30 - Earnings Summary
ClearPoint Neuro Q2 revenue rises 18% but misses estimates
Brief: ClearPoint Neuro Q2 Revenue USD 10.9 Million
ClearPoint Neuro Q1 revenue rises 43%, beats estimates
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition